Back to WA WOLVERINE ASSET MANAGEMENT LLC
PTGX
Showing 0 of 2 quarters
Position history for WAWOLVERINE ASSET MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
No. Wolverine Asset Management exited its PTGX (Protagonist Therapeutics) position in Q3 2019. Its Q2 2019 13F listed 80,000 shares worth $968,000. Wolverine Asset Management first reported PTGX in Q2 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.